Japan’s Asahi Kasei to buy German biotech Aicuris for $920Mnews2026-02-26T08:28:00+00:00February 26th, 2026|Endpoints News|
Novo Nordisk teams with Langer-founded biotech for oral obesity drugsnews2026-02-25T13:00:59+00:00February 25th, 2026|Endpoints News|
GSK to buy pulmonary hypertension biotech 35Pharma for $950Mnews2026-02-25T09:51:24+00:00February 25th, 2026|Endpoints News|
Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic pushnews2026-02-24T08:30:05+00:00February 24th, 2026|Endpoints News|
Astellas pays $240M cash for Vir’s prostate cancer drugnews2026-02-23T22:02:27+00:00February 23rd, 2026|Endpoints News|
Swiss Rockets buys MGI subsidiary Complete Genomics after Biosecure Actnews2026-02-23T19:56:05+00:00February 23rd, 2026|Endpoints News|
Fortress to sell priority review voucher for $205Mnews2026-02-23T19:34:21+00:00February 23rd, 2026|Endpoints News|
Gilead to buy cell therapy partner Arcellx in deal valued at $7.8Bnews2026-02-23T11:06:14+00:00February 23rd, 2026|Endpoints News|
Hims to buy Australia’s Eucalyptus for $240M upfront in global pushnews2026-02-19T14:52:28+00:00February 19th, 2026|Endpoints News|
Updated: Novartis signs macrocyclic deal with Unnatural Productsnews2026-02-18T15:45:20+00:00February 18th, 2026|Endpoints News|
